ABSTRACT Friend erythroleukemia cells temperature-sensitive (ts) for growth have been used to study the cell-cycle dependence of erythroid differentiation. ts cells accumulated hemoglobin in response to inducer when replicating optimally at permissive temperatures. However, when arrested in the GI phase of the cell cycle at a nonpermissive temperature, ts cells did not accumulate hemoglobin or globin mRNA nor did they differentiate terminally. Under these conditions, the viability of ts cells treated with inducer at the nonpermissive temperature remained high (70% of that of cells induced at the permissive temperature) as judged by cloning experiments. Total RNA and protein synthesis of G1 cells treated with inducer was 44-48% ofthat ofrandomly proliferating induced cells, in contrast to thymidine incorporation into DNA which decreased to 2% of that of cells replicating at the permissive temperature. Furthermore, GI ts cells treated with inducer accumulated hemoglobin when released from growth arrest at the permissive temperature in the presence (but not in the absence) of inducer. These results are consistent with a requirement for a cell cycle-dependent event prior to commitment to differentiation.
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A contentious issue in developmental biology is whether, in some instances, a change in the differentiated state of a cell is dependent on some prior cell-cycle event; for example, Holtzer et al. (1) have postulated a "quantal" cell cycle as the critical event that gives a daughter cell having metabolic options different from those of the immediate precursor. We have undertaken investigations to determine whether the induction of hemoglobin synthesis in Friend erythroleukemia cells is dependent on continued progress through the cell division cycle.
A correlation between the cell cycle of Friend cells and onset of induced hemoglobin production has been demonstrated (2, 3) , and exposure to inducer during at least one S phase of the cell cycle appears to be necessary for subsequent accumulation of globin mRNA (4) . Also consistent with the conclusion that induction is cell-cycle dependent is the finding that G1 or G2 Friend cells fractionated by unit gravity sedimentation give rise to a greater proportion of committed cells than unfractionated or S phase cells (5) . Furthermore, induction at GI/early S phase in cell fractions isolated by centrifugal elutriation permits accumulation of globin mRNA during the subsequent G1 phase whereas induction at late S/G2 does not (6) . Further data using sorted cells suggest that commitment to differentiation occurs only in G1 cells (7) . We have previously used single-cell analysis of Friend cells treated with inducers after growth arrest by metabolic inhibitors of DNA synthesis or by deprivation of isoleucine (8) . Such growth-arrested single cells did not synthesize hemoglobin, whereas cells that have divided once in the presence ofinducer prior to becoming growth arrested did. Reversal of growth arrest by amino acid deprivation permitted single uninduced cells to both replicate and accumulate hemoglobin in the presence of inducer.
By using a different erythroleukemia cell line (T3C12) growth arrested by hydroxyurea or cytosine arabinoside, we found that the single cells were inducible for hemoglobin by butyric acid, as reported (9) , but such induced cells were mainly binucleate (8) . Thus, DNA synthesis and nuclear division, rather than cytokinesis, may be required for induced hemoglobin synthesis. Indeed, it has been reported that multinucleate single cells treated with cytochalasin B are inducible for hemoglobin synthesis (10, 11) . However, Levenson et al. (12) have recently reported that inhibition of [3H]deoxyadenosine incorporation by fluorodeoxyuridine or excess thymidine during either the first or the latter half of the commitment period has no effect on the time at which cells become committed to differentiation. Also, inhibition of DNA synthesis subsequent to the commitment period does not prevent hemoglobin accumulation.
Possible side effects of growth arrest by using amino acid deprivation or drugs cannot be entirely excluded in most of these experiments. Therefore, we have adopted an alternative approach using conditional lethal mutants of Friend cells that are thermosensitive (ts) for growth, which we have isolated by a novel selection procedure (13) .
MATERIALS AND METHODS
Hexamethylenebisacetamide (HMBA) was a gift from Boyd Hardesty.
Friend Cells Temperature-Sensitive for Growth. The isolation ofconditional lethal mutant Friend cells ts for growth and their characterization and classification have been described (13) . Briefly, mutagenized cultures were subjected to five consecutive cycles of selection, each consisting of 48 hr of culture at 39°C in hypoxanthine/aminopterin/bromodeoxyuridine followed by exposure to near-visible light. This protocol selects against both wild-type replicating cells and cells lacking thymidine kinase, which are unable to incorporate bromodeoxyuridine, the lethal constituent. Survivors ofeach selection cycle were cloned at 33°C. Finally, replica plating permitted simultaneous clonal assessment of growth at 33°C and 39°C. Flow cytometry showed that, after 48 hr at 39°C, cells of the clone used (ts A54) accumulated in the G1 phase ofthe cell cycle (80% in G1, 15% in S, and 5% in G2/M).
Cell Culture. Cells were passaged and cultured at 2 X 104-1 X 105/ml in Ham's F-12 medium/15% fetal bovine serum (Flow Laboratories, Irvine, Scotland), batches of which were selected for their ability to support induction of differentiation in ts cells at permissive temperatures after a 30-hr exposure to the inducer followed by 114 hr of culture without inducer.
Abbreviations: ts, temperature sensitive; HMBA, hexamethylenebisacetamide.
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 Gl-arrested ts cells were allowed to return to proliferation during 30 hr of culture in the presence of inducer at the permissive temperature. They were then washed and incubated at the nonpermissive temperature for 52 hr without inducer and for 62 hr (still without inducer) at the permissive temperaturei.e., a total of 114 hr in culture after inducer treatment. This experiment produced 54% benzidine-positive cells having an average of 7 pg ofhemoglobin per cell (Table 2) . Thus, exposure to the nonpermissive conditions for up to 52 hr does not per se prevent the accumulation of hemoglobin. Furthermore, it is also clear from this experiment that postcommitment expression of the erythroid phenotype is not cell-cycle dependent.
In a further control experiment, exposure ofG -arrested cells to inducer first for 30 hr at 37.2500 and then for 18 or 114 hr at 34.2500 resulted in 18% or 62% of the cells, respectively, accumulating hemoglobin (Table 2) . Thus, the GI arrest is reversible, permitting both replication and differentiation. It is not yet known how short a time period (but less than 18 hr) in inducer at 34.2500, following the period of growth arrest, will produce cells committed to differentiation. (1981) cells even when proliferation is not affected (19) . However, in those experiments, total protein synthesis was inhibited 87%. In contrast, inhibition of protein synthesis by only 50% (i.e., to about the level in our G1-arrested ts cells) did not prevent commitment (19) . The present results with ts A54 cells showed no significant reduction in mean cellular hemoglobin concentration or proportion ofbenzidine-positive cells when treatment with inducer at 34.250C was followed by a period ofgrowth arrest. Therefore, postcommitment expression of differentiation is independent of the cell-division cycle. This is in agreement with the results of Levenson et al. (12) , who showed that inhibition of DNA synthesis by fluorodeoxyuridine did not affect postcommitment expression.
These results also show that, although both wild-type cells and ts cells accumulate hemoglobin in response to inducer at the permissive temperature, Gl-arrested ts cells cultured with HMBA at the nonpermissive temperature neither accumulate hemoglobin or globin mRNA nor do they differentiate morphologically or become committed to terminal differentiation. Thus the induction of Friend erythroleukemia cell differentiation appears to be dependent on some as yet unidentified cellcycle event.
As argued previously (20) , there may be a series of events necessary for Friend cell differentiation, some of which seem to be cell-cycle dependent whereas others are affected specifically by various inhibitors (19, 21 ). There appears to be general agreement that formation ofcells irreversibly committed to differentiation and the onset of globin mRNA accumulation occur first in G1 (5-7). Other work suggests that cells must pass through S phase in the presence of inducer for these events to occur (4), although the recent work of Levenson et al. (12) is not easily reconciled with this interpretation. It has not yet proved possible to determine which type of event our ts lesion is affecting; further experiments will be necessary to elucidate this point.
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